Drug industry steps up for credentialing group

Share this article:
The National Commission for the Certification of CME Professionals' voluntary certification program will not be out until fall 2007. That has not kept AstraZeneca and Merck, as well as several medical education entities from becoming “charter donors.” To earn the credential, candidates will have to meet specific criteria based on evidence of professional performance,
experience and completion of self-assessment, according to information on NC-CME.org.

Judy Ribble, PhD, NC-CME president, said she hopes small donations help the group attract a large foundation grant.

Maureen Doyle-Scharff, director of professional alliances, Ross, said, credentialing “would be a very positive step in the right direction from an industry perspective,” as a way to help ensure proposal competency.

Some medical societies agree, as their CME staffs need an increasingly broad skill set to collaborate on maintenance of certification.

Not everyone fully endorses NC-CME, and questions linger, such as who will pay for the
credential and test questions, who should take the exam and what's an apt re-certification plan.

Share this article:

Email Newsletters

More in News

Astellas, DOJ settle for $7.3M

Astellas, DOJ settle for $7.3M

Astellas has settled a False Claims case with the Department of Justice over the 2010-2013 marketing of an antifungal medication. Astellas denies the allegations.

Boehringer drug lands US, EU orphan tag

Boehringer drug lands US, EU orphan tag

The experimental Breakthrough Therapy treatment is for acute myeloid leukemia.

Omnio app moves to smartphones

Omnio app moves to smartphones

Physicians Interactive is introducing the third wave of its Omnio app, making the tablet-only tool available for iPhones and Android phones.